A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion

Trial Profile

A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion

Recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Aug 2018

At a glance

  • Drugs Alteplase (Primary) ; Aspirin
  • Indications Retinal vascular occlusion
  • Focus Therapeutic Use
  • Acronyms THEIA
  • Most Recent Events

    • 12 Jun 2018 Planned End Date changed from 1 Jan 2020 to 1 Sep 2020.
    • 12 Jun 2018 Planned primary completion date changed from 1 Jan 2020 to 1 Jun 2020.
    • 12 Jun 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top